Tomihisa, N., Masaomi, I. and Kenji, H. (2012) Sigma-1 Receptor Agonists as Therapeutic Drugs for Cognitive Impairment in Neuropsychiatric Diseases. Current Pharmaceutical Design, 18, 875-883.

医药行业商誉减值成因及防范分析——以众生药业为例
Analysis on the Causes and Prevention of Goodwill Impairment in Pharmaceutical Industry—Taking Guangdong Zhongsheng Pharmaceutical Co., Ltd. as an Example

徐嘉鑫, 何丽梅    科研立项经费支持

金融Vol.12 No.1, 全文下载: PDF HTML XML DOI:10.12677/FIN.2022.121007, January 17 2022

阿尔茨海默病化学合成药及生物技术药物药的研究进展
Research Progress of Chemical Synthesis Drugs and Biotechnology Drugs for Alzheimer’s Disease

陈学权, 郑文彬, 车土玲, 聂奕玮, 周文庆, 苏裕盛    科研立项经费支持

自然科学Vol.12 No.2, 全文下载: PDF HTML XML DOI:10.12677/ojns.2024.122051, March 31 2024

经颅直流电刺激联合认知康复训练对脑卒中后认知障碍的疗效观察及分析
Effect and Analysis of Transcranial Direct Current Stimulation Combined with Cognitive Rehabilitation Training on Post-Stroke Cognitive Impairment

宋梦涵, 朱其秀, 高呈飞, 张 红, 刘艳林    科研立项经费支持

临床医学进展Vol.13 No.5, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.1351172, May 25 2023

经颅直流电刺激对2型糖尿病合并轻度认知功能障碍的影响
Effect of Transcranial Direct Current Stimulation on Type 2 Diabetes Mellitus with Mild Cognitive Impairment

甘腾飞, 卜宪聪, 李增超, 左玉峰, 孙锦平   

临床医学进展Vol.12 No.2, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.122158, February 18 2022

急性缺血性脑卒中后认知障碍的危险因素分析及银杏二萜内酯的疗效分析
Analysis of Risk Factors of Cognitive Impairment after Acute Ischemic Stroke and Therapeutic Effect of Ginkgo Diterpene Lactone

李淑雅, 董胜璞, 薛延莉   

临床医学进展Vol.12 No.7, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.127946, July 15 2022

胰高血糖素样肽-1受体激动剂生物及临床研究进展
Advances in Biological and Clinical Research of GLP-1 Receptor Agonists

李 鑫, 江 彤   

临床医学进展Vol.12 No.4, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.124430, April 21 2022